Title : Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia.

Pub. Date : 2021 Sep 14

PMID : 34461632






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Given bortezomib"s activity in relapsed ALL and its synergism with rituximab in B-cell lymphomas, the addition of bortezomib to rituximab and chemotherapy may provide an incremental benefit in CD20-positive-precursor B-cell ALL. Bortezomib keratin 20 Homo sapiens